C Simard

Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema

Engineering precision nanoparticles for drug delivery

Classification and Grading of Gastritis

Lipid nanoparticles for mRNA delivery

Pharmacological targeting of endoplasmic reticulum stress in disease

Hallmarks of aging: An expanding universe

Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases

Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis

Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis

Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis

Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors

Nanomaterial Delivery Systems for mRNA Vaccines

Contribution of Organofluorine Compounds to Pharmaceuticals

Immune complex glomerulonephritis in sicca syndrome

Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury

Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer

A Survey of the Structures of US FDA Approved Combination Drugs

Chronic graft-versus-host syndrome in man

Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

[Chronic atrophic gastritis with carcinoid tumor and microcarcinoidosis. Report of a case with immunohistochemistry and ultrastructure study].

[Gougerot-Sjögren syndrome and glomerulonephritis].

VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles